NEM Insider Notice: 2,080 Shares Proposed Sale on NYSE, Oct 1 2025
Rhea-AI Filing Summary
Form 144 filed for Newmont Corp (NEM) reports a proposed sale of 2,080 common shares via Fidelity Brokerage Services on the NYSE, with an approximate sale date of 10/01/2025. The filing shows an aggregate market value of $176,779.20 and states Newmont has 1,098,449,725 shares outstanding, so the proposed sale is a very small portion of outstanding stock. The shares were originally acquired through restricted stock vesting on 04/26/2012 (361 shares) and 04/25/2013 (1,719 shares), both as compensation. The filing also discloses three prior sales by Bruce R. Brook in Jul, Aug, and Sep 2025 of 2,077 shares each, with gross proceeds listed for each sale. The signer certifies no undisclosed material information.
Positive
- Clear disclosure of broker, sale date, aggregate market value, and exchange (Fidelity / NYSE)
- Acquisition history provided (restricted stock vesting dates and amounts), supporting compliance with transfer rules
Negative
- None.
Insights
TL;DR: Insider plans to sell 2,080 NEM shares (small vs. 1.098B outstanding); prior monthly sales also disclosed.
The filing shows a routine Rule 144 notice for the proposed disposition of 2,080 common shares with an aggregate market value of $176,779.20 and an approximate trade date of 10/01/2025. Acquisition history indicates the shares were compensation-based restricted stock vesting in 2012 and 2013, which supports compliance with transfer restrictions. Recent monthly disposals in Jul–Sep 2025 (2,077 shares each) are disclosed, providing transparency on insider activity. Given the small size relative to total shares outstanding, the direct market impact is likely negligible, though continued patterned selling may be of interest to some investors.
TL;DR: Filing meets Rule 144 disclosure requirements; it documents vesting origins and recent sales, signaling procedural compliance.
The notice properly identifies the broker, contemplated sale volume, acquisition dates, and nature of acquisition (restricted stock vesting), which facilitates shareholder oversight. The signer’s representation regarding the absence of undisclosed material information is included, aligning with regulatory expectations. From a governance perspective, the filing demonstrates adherence to disclosure rules but does not by itself indicate management intent or trigger governance concerns given the immaterial size of the sale versus outstanding shares.